|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/295 | (2006.01) |
| C12N2710/20034 | (2013.01) | ||
| A61K 39/12 | (2006.01) | ||
| C12N2770/32434 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| C12N2770/24122 | (2013.01) | ||
| A61K 39/125 | (2006.01) | ||
| A61P 31/14 | (2018.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61K 39/29 | (2006.01) | ||
| A61P 31/04 | (2006.01) | ||
| A61K 39/12 | (2013.01) | ||
| A61P 31/14 | (2006.01) | ||
| C12N2770/24134 | (2013.01) | ||
| C12N2770/24171 | (2013.01) | ||
| A61K2039/545 | (2013.01) | ||
| A61K2039/575 | (2013.01) | ||
| A61K2039/5254 | (2013.01) | ||
| A61K 39/0018 | (2013.01) | ||
| A61K2039/572 | (2013.01) | ||
| A61K2039/70 | (2013.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Number of the document | 3620174 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19195692.9 |
| Date of filing the European patent application | 2019-09-05 | |
| (97) | Date of publication of the European application | 2020-03-11 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-19 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201916295611 | 2019-03-07 | US | |
| 18192701 | 2018-09-05 | EP | |
| 18192776 | 2018-09-05 | EP | |
| 18192787 | 2018-09-05 | EP | |
| 18192793 | 2018-09-05 | EP | |
| 18192800 | 2018-09-05 | EP | |
| 18192711 | 2018-09-05 | EP | |
| 18192717 | 2018-09-05 | EP | |
| 18192814 | 2018-09-05 | EP | |
| 19154334 | 2019-01-29 | EP | |
| 19161184 | 2019-03-07 | EP |
| (72) |
WALLACE, Derek , US
LEFEVRE, Inge , CH
|
| (73) |
Takeda Vaccines, Inc. ,
75 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | DENGUE VACCINE UNIT DOSE AND ADMINISTRATION THEREOF |
| DENGUE VACCINE UNIT DOSE AND ADMINISTRATION THEREOF |